|
1
|
Vilar L, Vilar CF, Lyra R, Lyra R and
Naves LA: Acromegaly: Clinical features at diagnosis. Pituitary.
20:22–32. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Broersen LHA, Zamanipoor Najafabadi AH,
Pereira AM, Dekkers OM, van Furth WR and Biermasz NR: Improvement
in symptoms and health-related quality of life in acromegaly
patients: A systematic review and meta-analysis. J Clin Endocrinol
Metab. 106:577–587. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Giustina A, Barkhoudarian G, Beckers A,
Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M,
Bollerslev J, Bonert V, et al: Multidisciplinary management of
acromegaly: A consensus. Rev Endocr Metab Disord. 21:667–678.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kanaka-Gantenbein C, Kogia C, Abdel-Naser
MB and Chrousos GP: Skin manifestations of growth hormone-induced
diseases. Rev Endocr Metab Disord. 17:259–267. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Degirmentepe EN, Gungor S, Kocaturk E,
Kiziltac U, Adas M, Ozekinci S and Khachemoune A: Dermatologic
manifestations of acromegaly: A case in point and a focused review.
Dermatol Online J. 23(13030/qt50s903qh)2017.PubMed/NCBI
|
|
6
|
Lause M, Kamboj A and Fernandez Faith E:
Dermatologic manifestations of endocrine disorders. Transl Pediatr.
6:300–312. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alotaibi A, Habib A, Osman M, Alzahrani K
and Alzahrani F: Pseudoacromegaly associated with non-functioning
pituitary adenoma. Eur J Case Rep Intern Med.
7(001950)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Joshi A, Nepal G, Shing YK, Panthi HP and
Baral S: Pachydermoperiostosis (touraine-solente-gole syndrome): A
case report. J Med Case Rep. 13(39)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Prerna Ghosh R, Barua JK and Das AK:
Pachydermoperiostosis mimicking acromegaly: A case report. Indian
Dermatol Online J. 9:182–184. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tritos NA, Chanson P, Jimenez C, King D,
Jönsson PJ, Klibanski A and Biller BM: Effectiveness of first-line
pegvisomant monotherapy in acromegaly: An ACROSTUDY analysis. Eur J
Endocrinol. 176:213–220. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gentile S, Strollo F and Ceriello A:
AMD-OSDI Injection Technique Study Group. Lipodystrophy in
insulin-treated subjects and other injection-site skin reactions:
Are we sure everything is clear? Diabetes Ther. 7:401–409.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Osher E and Macaulay VM: Therapeutic
targeting of the IGF axis. Cells. 8(895)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Qian Y, Basu R, Mathes SC, Arnett NA,
Duran-Ortiz S, Funk KR, Brittain AL, Kulkarni P, Terry JC, Davis E,
et al: Growth hormone upregulates mediators of melanoma drug efflux
and epithelial-to-mesenchymal transition in vitro and in vivo.
Cancers (Basel). 12(3640)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Valea A, Ghervan C, Carsote M, Morar A,
Iacob I, Tomesc F, Pop DD and Georgescu C: Effects of combination
therapy: Somatostatin analogues and dopamine agonists on GH and
IGF1 levels in acromegaly. Clujul Med. 88:310–313. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Qian F and Huo D: Circulating insulin-like
growth factor-1 and risk of total and 19 site-specific cancers:
Cohort study analyses from the UK Biobank. Cancer Epidemiol
Biomarkers Prev. 29:2332–2342. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Knuppel A, Fensom GK, Watts EL, Gunter MJ,
Murphy N, Papier K, Perez-Cornago A, Schmidt JA, Smith Byrne K,
Travis RC and Key TJ: Circulating insulin-like growth factor-i
concentrations and risk of 30 cancers: Prospective analyses in UK
Biobank. Cancer Res. 80:4014–4021. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
An LF, Huang JW, Han X and Wang J:
Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin
by regulating the miR-18b/IGF1 axis. Anticancer Drugs. 31:473–482.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yuan TA, Yourk V, Farhat A, Guo KL, Garcia
A, Meyskens FL and Liu-Smith F: A possible link of genetic
variations in ER/IGF1R pathway and risk of melanoma. Int J Mol Sci.
21(1776)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xie X, Xie S, Xie C, Fang Y, Li Z, Wang R
and Jiang W: Pristimerin attenuates cell proliferation of uveal
melanoma cells by inhibiting insulin-like growth factor-1 receptor
and its downstream pathways. J Cell Mol Med. 23:7545–7553.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Suleymanova N, Crudden C, Worrall C, Dricu
A, Girnita A and Girnita L: Enhanced response of melanoma cells to
MEK inhibitors following unbiased IGF-1R down-regulation.
Oncotarget. 8:82256–82267. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Terzolo M, Puglisi S, Reimondo G,
Dimopoulou C and Stalla GK: Thyroid and colorectal cancer screening
in acromegaly patients: Should it be different from that in the
general population? Eur J Endocrinol. 183:D1–D13. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kasuki L, Rocha PDS, Lamback EB and
Gadelha MR: Determinants of morbidities and mortality in
acromegaly. Arch Endocrinol Metab. 63:630–637. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ku CR, Melnikov V, Zhang Z and Lee EJ:
Precision therapy in acromegaly caused by pituitary tumors: How
close is it to reality? Endocrinol Metab (Seoul). 35:206–216.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sandru F, Draghici CC, Predescu T,
Constantin M, Petca RC, Constantin T, Petca A and Cristian
Dumitraşcu M: Regressive melanoma in a female patient: A case
report. Exp Ther Med. 20:87–90. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shirinpour Z, Farhangiyan Z, Akiash N and
Rashidi H: Recurrent cardiac and skin myxomas along with
acromegaly: A case report of carney complex. ARYA Atheroscler.
16:146–150. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kamilaris CDC, Faucz FR, Voutetakis A and
Stratakis CA: Carney complex. Exp Clin Endocrinol Diabetes.
127:156–164. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Subbiah S, Palikhe G, Bhadada SK,
Mukherjee KK and Bhansali A: Acrogigantism and facial asymmetry:
McCune-Albright syndrome. J Pediatr Endocrinol Metab. 24:835–837.
2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hozumi K, Fukuoka H, Odake Y, Takeuchi T,
Uehara T, Sato T, Inoshita N, Yoshida K, Matsumoto R, Bando H, et
al: Acromegaly caused by a somatotroph adenoma in patient with
neurofibromatosis type 1. Endocr J. 66:853–857. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hannah-Shmouni F and Stratakis CA: Growth
hormone excess in neurofibromatosis 1. Genet Med. 21:1254–1255.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cambiaso P, Galassi S, Palmiero M,
Mastronuzzi A, Del Bufalo F, Capolino R, Cacchione A, Buonuomo PS,
Gonfiantini MV, Bartuli A, et al: Growth hormone excess in children
with neurofibromatosis type-1 and optic glioma. Am J Med Genet A.
173:2353–2358. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sandru F, Carsote M, Valea A, Albu SE,
Petca RC and Dumitrascu MC: Somatostatinoma: Beyond
neurofibromatosis type 1 (review). Exp Ther Med. 20:3383–3388.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Valea A, Carsote M, Ghervan C and
Georgescu C: Glycemic profile in patients with acromegaly treated
with somatostatin analogue. J Med Life. 8 (Spec Issue):82–86.
2015.PubMed/NCBI
|
|
33
|
Ozarslan B, Russo T, Argenziano G, Santoro
C and Piccolo V: Cutaneous findings in neurofibromatosis type 1.
Cancers (Basel). 13(463)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Buchholzer S, Verdeja R and Lombardi T:
Type I neurofibromatosis: Case report and review of the literature
focused on oral and cutaneous lesions. Dermatopathology (Basel).
8:17–24. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kundak S and Çakır Y: Juvenile
xanthogranuloma: Retrospective analysis of 44 pediatric cases
(single tertiary care center experience). Int J Dermatol.
60:564–569. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Anderson S: Café au lait macules and
associated genetic syndromes. J Pediatr Health Care. 34:71–81.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ntala C and Biswas A: Spectrum of
melanocytic proliferation/differentiation in a large series of
cutaneous neurofibromas: An under-recognized histopathologic
phenomenon and potential clue for neurofibromatosis type 1. Am J
Dermatopathol. 42:165–172. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Radman M and Milicevic T: A novel mutation
of the MEN1 gene in a patient with multiple endocrine neoplasia
type 1 and recurrent fibromyxoid sarcoma-a case report. BMC Med
Genet. 21(190)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pérez AD, Yu S and North JP: Multiple
cutaneous collagenomas in the setting of multiple endocrine
neoplasia type 1. J Cutan Pathol. 42:791–795. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Sandru F, Carsote M, Albu SE, Valea A,
Petca A and Dumitrascu MC: Glucagonoma: From skin lesions to the
neuroendocrine component (review). Exp Ther Med. 20:3389–3393.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Brown GT, Cowen EW and Lee CC: Malignant
melanoma masquerading as an angiofibroma in a patient with MEN-1.
JAMA Dermatol. 151:105–106. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Keen MA, Shah IH and Sheikh G: Cutaneous
manifestations of polycystic ovary syndrome: A cross-sectional
clinical study. Indian Dermatol Online J. 8:104–110.
2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pardeshi SS, Khemani UN, Kamath RR, Kura
MM and Jafferany M: Therapeutic implications of dermoscopic
findings in acanthosis nigricans: A clinical and histopathological
study. Dermatol Ther. 33(e14521)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yilmaz B and Yildiz BO: Endocrinology of
hirsutism: From androgens to androgen excess disorders. Front Horm
Res. 53:108–119. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ng HY: Acanthosis nigricans in obese
adolescents: Prevalence, impact, and management challenges. Adolesc
Health Med Ther. 8:1–10. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
De Sanctis V, Soliman A, Marsciani A,
Timoncini G, Reggiani L, Zucchini A and Altieri E: Acanthosis
nigricans in adolescents: A practical approach. Georgian Med News.
73–78. 2013.PubMed/NCBI
|
|
47
|
Bhagyanathan M, Dhayanithy D, Parambath VA
and Bijayraj R: Acanthosis nigricans: A screening test for insulin
resistance-an important risk factor for diabetes mellitus type-2. J
Family Med Prim Care. 6:43–46. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kutlubay Z, Engin B, Bairamov O and Tüzün
Y: Acanthosis nigricans: A fold (intertriginous) dermatosis. Clin
Dermatol. 33:466–470. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Akoglu G, Metin A, Emre S, Ersoy R and
Cakir B: Cutaneous findings in patients with acromegaly. Acta
Dermatovenerol Croat. 21:224–229. 2013.PubMed/NCBI
|
|
50
|
Buslach N, Foulad DP, Saedi N and
Mesinkovska NA: Treatment modalities for cherry angiomas: A
systematic review. Dermatol Surg. 46:1691–1697. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Darjani A, Rafiei R, Shafaei S, Rafiei E,
Eftekhari H, Alizade N, Gharaei Nejad K, Rafiee B and Najirad S:
Evaluation of lipid profile in patients with cherry angioma: A
case-control study in Guilan, Iran. Dermatol Res Pract.
2018(4639248)2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Resende M, Bolfi F, Nunes Vdos S and Miot
HA: Prevalence of dermatologic disorders in 15 patients with
acromegaly. An Bras Dermatol. 87:166–168. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Füchtbauer L, Olsson DS, Coopmans EC,
Bengtsson BÅ, Norrman LL, Neggers SJCMM, Hellström A and Johannsson
G: Increased number of retinal vessels in acromegaly. Eur J
Endocrinol. 182:293–302. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Haddad A, Ashkenazi RI, Bitterman H,
Feldhamer I, Greenberg-Dotan S, Lavi I, Batat E, Bergman I, Cohen
AD and Zisman D: Endocrine comorbidities in patients with psoriatic
arthritis: A population-based case-controlled study. J Rheumatol.
44:786–790. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Bolfi F, Miot HA, Resende M, Mazeto GM,
Romeiro FG, Yamashiro Fda S and Nunes Vdos S: Frequency of various
types of neoplasia in a group of acromegalic patients. Arq Bras
Endocrinol Metabol. 57:612–616. 2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Scheinfeld N: Diseases associated with
hidranitis suppurativa: Part 2 of a series on hidradenitis.
Dermatol Online J. 19(18558)2013.PubMed/NCBI
|
|
57
|
Manavela M, Vigovich C, Danilowicz K, Juri
A, Miechi L, Fernandez Valoni V and Bruno OD: Thyroid autoimmune
disorders in patients with acromegaly. Pituitary. 18:912–915.
2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Falcone M, Meier JJ, Marini MG,
Caccialanza R, Aguado JM, Del Prato S and Menichetti F: Diabetes
and acute bacterial skin and skin structure infections. Diabetes
Res Clin Pract. 174(108732)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Papachristou S, Pafili K and Papanas N:
Skin AGEs and diabetic neuropathy. BMC Endocr Disord.
21(28)2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Naik PP and Farrukh SN: Clinical
significance of diabetic dermatopathy. Diabetes Metab Syndr Obes.
13:4823–4827. 2020.PubMed/NCBI View Article : Google Scholar
|
